🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or prison.

Platform Response and Content Elimination

According to the social media company, the platform has removed problematic material and banned related keywords and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.

After minutes of joining one community, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.